Date: Nov 18, 2025 01:00 PM - Nov 25, 2025 02:30 AM
Fee
$0.00
CE Hours
1.50
CE Units
0.150
Registration closes on Dec 31, 2025 10:00 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacist
Accreditation(s)
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Objectives
- Describe the role of long-acting injectable therapies in the treatment and prevention of HIV.
- Outline currently available long-acting agents in terms of mechanism, dosing, schedule, and indications.
- Explain clinical trial data supporting the use of lenacapavir for HIV PrEP.
- Identify appropriate candidates for long-acting injectable PrEP and ART, with consideration for adherence, stigma, and access barriers.
Speaker(s)/Author(s)
|
Dr. Caitlin Prather |
Activity Number
0010-9999-25-064-L02-P
Date:
11/18/25
Time:
01:00 PM - 02:30 PM
CE Hours
1.50